|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
3 August 2015 |
|
Main ID: |
NCT01974739 |
|
Date of registration:
|
28/10/2013 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Hydrochloorthiazide and Hypernatriaemie
|
|
Scientific title:
|
Hypernatraemia and Diuretics in Intensive Care Patients |
|
Date of first enrolment:
|
September 2013 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01974739 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
Christiaan Boerma, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Medical Centre Leeuwarden |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- sodium > 142
Exclusion Criteria:
- no informed consent
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypernatraemia
|
|
Intervention(s)
|
|
Drug: placebo
|
|
Drug: Hydrochloorthiazide
|
|
Primary Outcome(s)
|
|
sodium level
[Time Frame: 7 days]
|
|
Secondary Outcome(s)
|
|
time hypernatraemia
[Time Frame: 7 days]
|
|
Secondary ID(s)
|
|
ABR 44878
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|